September 12, 2022, President Biden signed the “Executive Order on Advancing Biotechnology and Biomanufacturing Innovation for a Sustainable, Safe and Secure American Bioeconomy.”1
Specified in that order is the development of genetic engineering technologies and techniques “to be able to write circuitry for cells and predictably program biology in the same way in which we write software and program computers,” as well as genetic technologies to “unlock the power of biological data” using “computing tools and artificial intelligence.”
Additionally, “obstacles for commercialization” will be reduced “so that innovative technologies and products can reach markets faster.” What we have here is, in a nutshell, the creation of a fast-tracked mRNA pipeline.
When, in June 2022, the U.S. Food and Drug Administration quietly implemented a “Future Framework” scheme 2 to deliver reformulated COVID boosters without additional testing, I predicted that this “no testing r...